Fu S

564 total citations · 1 hit paper
19 papers, 411 citations indexed

About

Fu S is a scholar working on Parasitology, Epidemiology and Surgery. According to data from OpenAlex, Fu S has authored 19 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Parasitology, 5 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Fu S's work include Parasites and Host Interactions (6 papers), Liver Disease Diagnosis and Treatment (4 papers) and MicroRNA in disease regulation (2 papers). Fu S is often cited by papers focused on Parasites and Host Interactions (6 papers), Liver Disease Diagnosis and Treatment (4 papers) and MicroRNA in disease regulation (2 papers). Fu S collaborates with scholars based in China, United States and Iran. Fu S's co-authors include Daopeng Yang, Sheng-Feng Lu, Yimin Zhu, Xiangyu Wang, Xiaomin Song, Xueqing Wu, Hailan Feng, R. Li, Zhaolian Wei and Qing Zhang and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Human Reproduction and Plastic & Reconstructive Surgery.

In The Last Decade

Fu S

19 papers receiving 396 citations

Hit Papers

Prevalence of polycystic ovary syndrome in women in China... 2013 2026 2017 2021 2013 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prevalence of polycystic ovary syndrome in women in China: a large community-based study
    2013 301 citations R. Li, Qing Zhang et al. Human Reproduction profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fu S China 8 277 197 56 37 33 19 411
J. Callejo Spain 8 229 0.8× 202 1.0× 37 0.7× 33 0.9× 26 0.8× 16 344
Jolanta Nawrocka-Rutkowska Poland 11 248 0.9× 125 0.6× 36 0.6× 43 1.2× 27 0.8× 31 374
Dean M. Moutos United States 10 167 0.6× 160 0.8× 64 1.1× 25 0.7× 35 1.1× 18 378
Sang Ho Yoon South Korea 15 335 1.2× 217 1.1× 57 1.0× 95 2.6× 42 1.3× 34 507
Anastasios Makedos Greece 11 293 1.1× 157 0.8× 35 0.6× 45 1.2× 29 0.9× 17 454
Suchada Indhavivadhana Thailand 11 256 0.9× 149 0.8× 26 0.5× 87 2.4× 35 1.1× 32 401
Eftihios Trakakis Greece 14 226 0.8× 123 0.6× 124 2.2× 128 3.5× 31 0.9× 36 467
Ariel Zosmer United Kingdom 13 347 1.3× 281 1.4× 45 0.8× 39 1.1× 39 1.2× 32 590
Alice Albu Romania 12 152 0.5× 103 0.5× 44 0.8× 96 2.6× 17 0.5× 32 334
Francesca Sagnella Italy 12 269 1.0× 170 0.9× 31 0.6× 78 2.1× 10 0.3× 18 366

Countries citing papers authored by Fu S

Since Specialization
Citations

This map shows the geographic impact of Fu S's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu S with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu S more than expected).

Fields of papers citing papers by Fu S

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fu S. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu S. The network helps show where Fu S may publish in the future.

Co-authorship network of co-authors of Fu S

This figure shows the co-authorship network connecting the top 25 collaborators of Fu S. A scholar is included among the top collaborators of Fu S based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fu S. Fu S is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cai, Guangyan, Kai Wang, Jun Zhao, et al.. (2024). Neoadjuvant Camrelizumab Combined with Chemotherapy for Resectable Stage IIIA-IIIB Non-Small Cell Lung Cancer: Single Arm Phase II Study. International Journal of Radiation Oncology*Biology*Physics. 120(2). e10–e10. 1 indexed citations
2.
S, Fu, Mengmeng Xu, Siyi Wang, et al.. (2024). HDAC6 inhibitor ACY-1215 protects from nonalcoholic fatty liver disease via inhibiting CD14/TLR4/MyD88/MAPK/NFκB signal pathway. Heliyon. 10(13). e33740–e33740. 3 indexed citations
3.
S, Fu, et al.. (2024). Effect of Antidepressants on Non-alcoholic Fatty Liver Disease and their Underlying Mechanism. Current Medicinal Chemistry. 32(35). 7925–7937. 2 indexed citations
4.
S, Fu, Jian Ping Gong, Mei Zhou, et al.. (2022). Risk Factors of Non-en Bloc Resection and Non-R0 Resection During Endoscopic Resection in the Treatment of Superficial Duodenal Epithelial Lesions. Frontiers in Oncology. 12. 881815–881815. 1 indexed citations
5.
S, Fu, et al.. (2022). Association between grip strength and non-alcoholic fatty liver disease: A systematic review and meta-analysis. Frontiers in Medicine. 9. 988566–988566. 3 indexed citations
6.
S, Fu, et al.. (2022). Role of Selective Histone Deacetylase 6 Inhibitor ACY-1215 in Cancer and Other Human Diseases. Frontiers in Pharmacology. 13. 907981–907981. 19 indexed citations
7.
S, Fu, Yan Jin, Yuyong Tan, & Deliang Liu. (2021). Prognostic value of systemic immune-inflammatory index in survival outcome in gastric cancer: a meta-analysis. Journal of Gastrointestinal Oncology. 12(2). 344–354. 23 indexed citations
8.
S, Fu, et al.. (2021). Metabolic syndrome is associated with higher rate of gastroesophageal reflux disease: a meta‐analysis. Neurogastroenterology & Motility. 34(5). e14234–e14234. 8 indexed citations
9.
S, Fu, et al.. (2020). Role of histone deacetylase on nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology. 15(4). 353–361. 8 indexed citations
10.
Li, R., Qing Zhang, Daopeng Yang, et al.. (2013). Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Human Reproduction. 28(9). 2562–2569. 301 indexed citations breakdown →
11.
S, Fu, et al.. (2000). Free Transfer of Expanded Parascapular, Latissimus Dorsi, and Expander “Capsule” Flap for Coverage of Large Lower-Extremity Soft-Tissue Defect. Plastic & Reconstructive Surgery. 106(2). 402–405. 13 indexed citations
12.
Xu, Gexi, et al.. (1996). [Intestinal flora in renal allograft recipients].. PubMed. 76(10). 759–62. 1 indexed citations
13.
S, Fu, et al.. (1991). Recent laboratory investigations by Chinese workers on antischistosomal activities of praziquantel.. PubMed. 104(7). 599–606. 7 indexed citations
14.
S, Fu, et al.. (1983). Immunologic function in schistosomiasis japonica patients before and after treatment.. PubMed. 96(12). 917–20. 1 indexed citations
15.
S, Fu, et al.. (1983). A retrospective survey on comparatively serious side-effects of pyquiton among 25,693 cases of schistosomiasis japonica.. 1(2). 74–77. 1 indexed citations
16.
S, Fu, et al.. (1983). A retrospective survey on side effects of praziquantel among 25,693 cases of schistosomiasis japonica.. PubMed. 14(4). 495–500. 16 indexed citations
17.
S, Fu, et al.. (1983). [Comparative study on various dose schedules of praziquantel in the treatment of schistosomiasis japonica].. PubMed. 1(1). 32–6. 1 indexed citations
18.
S, Fu, et al.. (1981). [Clinical studies on treatment of schistosomiasis japonica with a combination of pyquiton and furapromide].. PubMed. 3 Suppl 1. 66–8. 1 indexed citations
19.
S, Fu, et al.. (1981). [Analysis of 62 cases of acute schistosomiasis japonica treated with pyquiton or nithiocyamine].. PubMed. 3 Suppl 1. 52–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Callejo Breakdown of academic impact, for papers by Jolanta Nawrocka-Rutkowska Breakdown of academic impact, for papers by Dean M. Moutos Breakdown of academic impact, for papers by Sang Ho Yoon Breakdown of academic impact, for papers by Anastasios Makedos Breakdown of academic impact, for papers by Suchada Indhavivadhana Breakdown of academic impact, for papers by Eftihios Trakakis Breakdown of academic impact, for papers by Ariel Zosmer Breakdown of academic impact, for papers by Alice Albu Breakdown of academic impact, for papers by Francesca Sagnella
Rankless by CCL
2026